Fueled by a handful of trials and word-of-mouth buzz, low-dose naltrexone is gaining momentum among patients and some doctors ...

Tonmya demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT studyTreatment ...

In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights a pair of “timely and cool” stories on point-of-care AI use and the FDA approval of ...

Results of a systematic review and meta-analysis showed that LDN was safe and effective for reducing pain and improving ...

Tonix Pharmaceuticals (TNXP) presented data on Tonmya, which was investigated as TNX-102 SL, at the 2025 American College of Rheumatology ...

Discover essential insights on fibromyalgia, including symptoms, causes, diagnosis, and management strategies for effective ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated, commercial biotechnology ...